• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初次就诊中度至重度糖尿病足感染的微生物学检查与抗菌活性及喹诺酮单药治疗的调查。

Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.

机构信息

U.O. Malattie Infettive, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.

出版信息

Diabetes Res Clin Pract. 2011 Oct;94(1):133-9. doi: 10.1016/j.diabres.2011.07.017. Epub 2011 Aug 6.

DOI:10.1016/j.diabres.2011.07.017
PMID:21824673
Abstract

Samples from 1295 patients with diabetic foot infection were evaluated; 4332 samples were collected with an average of 3.3 samples per patient. Fifty-seven percent of patients had a 2B ulcer and 23% had a 3B ulcer according to Texas University Classification. In 64.2% of samples collected at first visit an etiologic agent was identified. About 40% of the positive samples were polymicrobial. Gram positive bacteria were more frequently isolated (52.6%), Staphylococcus aureus was the most frequently isolated single agent (29.9%) and MRSA was 22% of S. aureus. Enterococcus spp., mainly Enterococcus faecalis, were 9.9%, all vancomycin susceptible except 2 isolates. Streptococci were 4.6%, more than 60% Streptococcus agalactiae. Gram negative rods were 40.6%, with enterobacteria 23.5% and Pseudomonas aeruginosa 10.3%. Anaerobes were only 0.3%, probably due to culture methods applied in our laboratory. Cotrimoxazole, rifampin and doxycycline were still active against S. aureus. ESBL producers, among enterobacteria, were 10%, mainly Escherichia coli and Proteus spp. Only colistin had a rate of susceptibility against P. aeruginosa above 90%. Levofloxacin had the best clinical activity with respect to the other quinolones, but when it failed, selected more resistant strains with respect to moxifloxacin among S. aureus and with respect to ciprofloxacin among P. aeruginosa.

摘要

对 1295 例糖尿病足感染患者的样本进行了评估;每位患者平均采集 3.3 份样本,共采集了 4332 份样本。根据德克萨斯大学分类法,57%的患者有 2B 溃疡,23%的患者有 3B 溃疡。在首次就诊时采集的 64.2%的样本中确定了病原体。约 40%的阳性样本为混合感染。革兰氏阳性菌的分离率较高(52.6%),金黄色葡萄球菌是最常分离到的单一病原体(29.9%),耐甲氧西林金黄色葡萄球菌(MRSA)占金黄色葡萄球菌的 22%。肠球菌属,主要为粪肠球菌,占 9.9%,除 2 株外均对万古霉素敏感。链球菌属占 4.6%,超过 60%为无乳链球菌。革兰氏阴性杆菌占 40.6%,其中肠杆菌科占 23.5%,铜绿假单胞菌占 10.3%。厌氧菌仅占 0.3%,可能是由于我们实验室应用的培养方法。复方磺胺甲噁唑、利福平、多西环素对金黄色葡萄球菌仍有活性。肠杆菌科中 ESBL 产生菌占 10%,主要为大肠埃希菌和变形杆菌属。只有黏菌素对铜绿假单胞菌的敏感性率高于 90%。左氧氟沙星在其他喹诺酮类药物中具有最佳的临床疗效,但当它失败时,与莫西沙星相比,金黄色葡萄球菌中更耐药的菌株,与环丙沙星相比,铜绿假单胞菌中更耐药的菌株。

相似文献

1
Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.初次就诊中度至重度糖尿病足感染的微生物学检查与抗菌活性及喹诺酮单药治疗的调查。
Diabetes Res Clin Pract. 2011 Oct;94(1):133-9. doi: 10.1016/j.diabres.2011.07.017. Epub 2011 Aug 6.
2
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.在台湾,对具有不同耐药表型的金黄色葡萄球菌、肠球菌和肺炎链球菌的临床分离株进行体外药敏试验,评估新型非氟喹诺酮类药物奈莫沙星(TG-873870)的抗菌活性。
J Antimicrob Chemother. 2009 Dec;64(6):1226-9. doi: 10.1093/jac/dkp370. Epub 2009 Oct 14.
3
Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.马来西亚一家教学医院糖尿病足感染的微生物学:194例回顾性研究
J Microbiol Immunol Infect. 2007 Feb;40(1):39-44.
4
Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection.非甾体抗炎药对尿路感染和糖尿病足感染临床分离株的抗菌作用。
Pak J Pharm Sci. 2010 Jan;23(1):108-13.
5
In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.莫西沙星对台湾常见临床分离菌株的体外活性。
J Microbiol Immunol Infect. 2001 Sep;34(3):178-84.
6
Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.2004 年至 2009 年期间,在美国进行的替加环素评估和监测试验(TEST)中收集的革兰氏阳性分离株对替加环素和利奈唑胺的敏感性。
Clin Ther. 2011 Dec;33(12):1964-73. doi: 10.1016/j.clinthera.2011.10.010. Epub 2011 Nov 10.
7
[Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].[糖尿病足感染。致病微生物的患病率及抗生素敏感性]
Enferm Infecc Microbiol Clin. 2009 Jun;27(6):317-21. doi: 10.1016/j.eimc.2008.07.004. Epub 2009 Feb 23.
8
Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.氟喹诺酮类及其他抗生素对1116株临床革兰氏阳性和革兰氏阴性分离菌的抗菌活性。
Drugs Exp Clin Res. 1998;24(3):139-51.
9
[Clinical distribution and antimicrobial resistance analysis of 754 pathogenic bacteria in diabetic foot infection].754株糖尿病足感染病原菌的临床分布及耐药性分析
Zhonghua Yi Xue Za Zhi. 2014 Apr 1;94(12):889-94.
10
[Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002].[2002年从尿路感染患者中分离出的微生物的抗菌药敏性]
Jpn J Antibiot. 2006 Feb;59(1):21-8.

引用本文的文献

1
A Case of Recurrent Diabetic Foot Ulcers With Multi-drug Resistant Poly-Microbial Infections.一例复发性糖尿病足溃疡伴多重耐药性混合微生物感染病例
Cureus. 2024 Jul 26;16(7):e65432. doi: 10.7759/cureus.65432. eCollection 2024 Jul.
2
Is the Predominant Pathogen in Hospitalised Patients with Diabetes-Related Foot Infections: An Australian Perspective.糖尿病相关足部感染住院患者的主要病原体:澳大利亚视角
Antibiotics (Basel). 2024 Jun 26;13(7):594. doi: 10.3390/antibiotics13070594.
3
Anaerobes in diabetic foot infections: pathophysiology, epidemiology, virulence, and management.
糖尿病足感染中的厌氧菌:病理生理学、流行病学、毒力和治疗。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0014323. doi: 10.1128/cmr.00143-23. Epub 2024 May 31.
4
Deciphering Diabetic Foot Wounds: A Comprehensive Review on Classification, Multidrug Resistance, Microbial Insights, Management & Treatment Strategies, and Advanced Diagnostic Tools.解读糖尿病足伤口:关于分类、多重耐药性、微生物见解、管理与治疗策略以及先进诊断工具的综合综述
Curr Diabetes Rev. 2025;21(6):1-11. doi: 10.2174/0115733998287694240514110935.
5
Current Knowledge and Perspectives of Phage Therapy for Combating Refractory Wound Infections.噬菌体疗法在治疗耐药性创面感染中的研究现状和展望。
Int J Mol Sci. 2024 May 17;25(10):5465. doi: 10.3390/ijms25105465.
6
Multi-Instrumental Analysis Toward Exploring the Diabetic Foot Infection Microbiota.多仪器分析探索糖尿病足感染微生物组。
Curr Microbiol. 2023 Jul 5;80(8):271. doi: 10.1007/s00284-023-03384-z.
7
Cigarette Smoking and Peripheral Vascular Disease are Associated with Increasing Risk of ESKAPE Pathogen Infection in Diabetic Foot Ulcers.吸烟和外周血管疾病与糖尿病足溃疡中ESKAPE病原体感染风险增加相关。
Diabetes Metab Syndr Obes. 2022 Oct 26;15:3271-3283. doi: 10.2147/DMSO.S383701. eCollection 2022.
8
Microbial Infection and Antibiotic Susceptibility of Diabetic Foot Ulcer in China: Literature Review.中国糖尿病足溃疡的微生物感染与抗生素耐药性:文献综述。
Front Endocrinol (Lausanne). 2022 May 19;13:881659. doi: 10.3389/fendo.2022.881659. eCollection 2022.
9
Microbiological profile of diabetic foot ulcers in Kuwait.科威特糖尿病足溃疡的微生物学特征。
PLoS One. 2020 Dec 30;15(12):e0244306. doi: 10.1371/journal.pone.0244306. eCollection 2020.
10
Patient perceptions of phage therapy for diabetic foot infection.患者对噬菌体疗法治疗糖尿病足感染的看法。
PLoS One. 2020 Dec 14;15(12):e0243947. doi: 10.1371/journal.pone.0243947. eCollection 2020.